Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)

NCT06184581 is registered in ClinicalTrials.gov with University Hospital Bispebjerg and Frederiksberg as lead sponsor.

NCT NCT06184581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06184581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
Phase
Phase 4
Overall status
Recruiting
Start date
May 8, 2024
Completion date
December 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar ii disorder